WASHINGTON (Reuters) – A U.S. appeals court ruled Monday Volkswagen AG may face “enormous” additional liability in the “Dieselgate” scandal finding that two counties can enforce regulations against the German automaker for tampering with post-sale vehicles.

The court said it recognized the ruling “may result in the imposition of unexpected (and enormous) liability on Volkswagen.” Volkswagen admitted to using illegal software to cheat U.S. pollution tests in 2015, triggering a global backlash against diesel vehicles that has so far cost it 30 billion euros ($33.3 billion) in fines, penalties and buyback costs.

VW did not immediately comment.

Reporting by David Shepardson and Jonathan Stempel, Editing by Franklin Paul

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Luckin Coffee fires CEO and COO after accounting scandal

New York (CNN Business)Luckin Coffee fired its CEO after the Chinese homegrown rival to Starbucks was found to have fabricated sales. Jenny Zhiya Qian was terminated on Monday, along with chief operating officer Jian Lu — the executive whom the…

Tailored Brands may seek Chapter 11 protection if COVID effect continues

(Reuters) – Men’s Wearhouse owner Tailored Brands Inc (TLRD.N) said on Wednesday it may have to seek bankruptcy protection or discontinue operations, if the COVID-19 crisis continues to pummel sales. The retailer said it has taken “decisive actions to manage…

Mini Cooper goes electric

After years of experimental models and concept cars, BMW unveiled a fully electric Mini Cooper that you will be able to buy. Powered by a 181-horsepower electric motor that’s located under the hood, the front-wheel-drive Mini Cooper SE will deliver…

Gilead prices COVID-19 drug candidate remdesivir at $390/vial in U.S.

(Reuters) – Gilead Sciences Inc (GILD.O) said on Monday it has priced its COVID-19 treatment candidate remdesivir at $390 per vial in the United States and other developed countries. Based on current treatment patterns, the vast majority of patients are…